Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: Data from the colorectal cancer family registry

Cancer Prevention Research

Volumn 5, Issue 2, 2012, Pages 328-335

  Levine, A Joan ^a   Win, Aung Ko ^c   Buchanan, Daniel D ^d   Jenkins, Mark A ^c   Baron, John A ^e   Young, Joanne P ^d   Long, Tiffany I ^b   Weisenberger, Daniel J ^b   Laird, Peter W ^a   McCall, Rebecca L ^f   Duggan, David J ^f   Haile, Robert W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA GLYCOSYLASE MUTY; PROTEIN MLH1;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; DNA METHYLATION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PRIORITY JOURNAL; STOMACH CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84857683133     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0419     Document Type: Article

References (43)

1. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998;58:3455-60. (Pubitemid 28371090)
2. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998;95:6870-5. (Pubitemid 28278073)
3. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93. (Pubitemid 43980599)
4. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216-27. (Pubitemid 43083493)
5. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 2007;13: 356-61. (Pubitemid 46121890)
6. Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, et al. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009;18:967-75.
7. Chao A, Gilliland F, Willman C, Joste N, Chen IM, Stone N, et al. Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. Cancer Epidemiol Biomarkers Prev 2000;9:539-44. (Pubitemid 30396173)
8. Park IJ, Kim HC, Yoon YS, Yu CS, Jang SJ, Kim JC. Clinicopathological characteristics of colorectal cancer with family history: an evaluation of family history as a predictive factor for microsatellite instability. J Korean Med Sci 2007;22 Suppl:S91-7.
9. Slattery ML, Curtin K, Schaffer D, Anderson K, Samowitz W. Associations between family history of colorectal cancer and genetic alterations in tumors. Int J Cancer 2002;97:823-7. (Pubitemid 34106339)
10. de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, et al. MGMT and MLH1 promoter methylation versus APC,KRASand BRAFgene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 2009;20: 1216-22.
11. Samowitz WS, Slattery ML, Kerber RA. Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology 1995;109:1765-71.
12. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005;65:6063-9.
13. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-43. (Pubitemid 351196365)
14. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. eds. International classification of diseases for oncology. Geneva, Switzerland: World Health Organization; 2000.
15. Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, Lindor N, et al. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 2008;17:3208-15.
16. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005;33:6823-36. (Pubitemid 41830488)
17. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. The clinical phenotype of Lynch syndromedue to germ-line PMS2 mutations. Gastroenterology 2008;135:419-28.
18. Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005;23:6524-32. (Pubitemid 46190244)
19. Gould W. Jackknife estimation. Stata Technical Bulletin 1995;4:25-9.
20. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents. Vol VII. Lyon, France: IARC Cancer Base No. 7; 2005.
21. Ries LAG, Eisner MP, Kosary CL, Bankey HF, Miller BA, Clegg L, et al., editors. SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003. Available from: http://seer.cancer. gov/csr/1975-2000/.
22. StataCorp. Stata statistical software: release 11. College Station, TX: StatCorp LP; 2009.
23. Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, et al. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population- based study. Cancer Epidemiol Biomarkers Prev 2010;19: 1831-9.
24. Ricciardiello L, Goel A, Mantovani V, Fiorini T, Fossi S, Chang DK, et al. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res 2003;63:787-92. (Pubitemid 36231977)
25. Koh DC, Luchtefeld MA, Kim DG, Attal H, Monroe T, Ingersoll K. Microsatellite instability and MLH1 hypermethylation - incidence and significance in colorectal polyps in young patients. Colorectal Dis 2007;9:521-6. (Pubitemid 46958542)
26. Kim JC, Lee KH, Ka IH, Koo KH, Roh SA, Kim HC, et al. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling Amsterdam criteria. Clin Cancer Res 2004;10:6159-68. (Pubitemid 39287522)
27. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45. (Pubitemid 41242676)
28. Young J, Jass JR. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 2006;15:1778-84. (Pubitemid 44664248)
29. Hitchins MP, Ward RL. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet 2009;46:793-802.
30. Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 2010;25:33-42.
31. Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH. Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 2009;10:400-8.
32. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 2004;53:1322-8. (Pubitemid 39120120)
33. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;92:144-50. (Pubitemid 32187044)
34. Hemminki K, Vaittinen P. Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev 1997;6:993-7. (Pubitemid 28007407)
35. Negri E, Braga C, La Vecchia C, Franceschi S, Filiberti R, Montella M, et al. Family history of cancer and risk of colorectal cancer in Italy. Br J Cancer 1998;77:174-9. (Pubitemid 28029792)
36. Ottini L, Falchetti M, Lupi R, Rizzolo P, Agnese V, Colucci G, et al. Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol 2006;17 Suppl 7:vii97-102.
37. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah Population Database. J Natl Cancer Inst 1994;86:1618-26. (Pubitemid 24336348)
38. Tung KH, Goodman MT,Wu AH, McDuffie K, Wilkens LR, Nomura AM, et al. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol 2004; 159:750-8. (Pubitemid 38656132)
39. Soegaard M, Frederiksen K, Jensen A, Høgdall E, Høgdall C, Blaakaer J, et al. Risk of ovarian cancer in women with first-degree relatives with cancer. Acta Obstet Gynecol Scand 2009;88:449-56.
40. Pal T, Permuth-Wey J, Kumar A, Sellers TA. Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology. Clin Cancer Res 2008;14:6847-54.
41. Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, et al. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst 2007;99:463-74. (Pubitemid 47078735)
42. Young J, Barker MA, Simms LA, Walsh MD, Biden KG, Buchanan D, et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005;3:254-63. (Pubitemid 40568731)
43. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003;24:190-8. (Pubitemid 36144098)